Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Intervention for Veterans With PTSD
NCT04150380Phase 2Completed
- Sponsor
- VA Eastern Colorado Health Care System
- Start
- Aug 2020
- Primary completion
- Dec 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lactobacillus rhamnosus GG in post-traumatic stress disorder (PTSD) and functional bowel disorder (FBD) (2 arms), sponsored by VA Eastern Colorado Health Care System. Primary endpoint: Plasma concentration of C-reactive protein at 8 weeks. Started Aug 2020; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
post-traumatic stress disorder (PTSD)functional bowel disorder (FBD)
Beyond the preview
Go deeper on NCT04150380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150380.